Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 474 entries
Sorted by: Best Match Show Resources per page
Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact.

BMC public health

McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O'Flaherty M, Taylor-Robinson D, Guzman-Castillo M, Gillespie D, Moreira P, Allen K, Hyseni L, Calder N, Petticrew M, White M, Whitehead M, Capewell S.
PMID: 26373840
BMC Public Health. 2015 Sep 15;15:894. doi: 10.1186/s12889-015-2162-y.

No abstract available.

Cite
McGill R, Anwar E, Orton L, et al. Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health. 2015;15:894doi: 10.1186/s12889-015-2162-y.
McGill, R., Anwar, E., Orton, L., Bromley, H., Lloyd-Williams, F., O'Flaherty, M., Taylor-Robinson, D., Guzman-Castillo, M., Gillespie, D., Moreira, P., Allen, K., Hyseni, L., Calder, N., Petticrew, M., White, M., Whitehead, M., & Capewell, S. (2015). Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC public health, 15894. https://doi.org/10.1186/s12889-015-2162-y
McGill, Rory, et al. "Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact." BMC public health vol. 15 (2015): 894. doi: https://doi.org/10.1186/s12889-015-2162-y
McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O'Flaherty M, Taylor-Robinson D, Guzman-Castillo M, Gillespie D, Moreira P, Allen K, Hyseni L, Calder N, Petticrew M, White M, Whitehead M, Capewell S. Erratum to: Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact. BMC Public Health. 2015 Sep 15;15:894. doi: 10.1186/s12889-015-2162-y. PMID: 26373840; PMCID: PMC4571134.
Copy Download .nbib Format: NLM
Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report.

Case reports in nephrology

Tavares I, Lobato L, Matos C, Santos J, Moreira P, Saraiva MJ, Castro Henriques A.
PMID: 26199771
Case Rep Nephrol. 2015;2015:919763. doi: 10.1155/2015/919763. Epub 2015 Jun 23.

Systemic hereditary amyloidoses are autosomal dominant diseases associated with mutations in genes encoding ten different proteins. The clinical phenotype has implications on therapeutic approach, but it is commonly variable and largely dependent on the type of mutation. Except for...

Cite
Tavares I, Lobato L, Matos C, et al. Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report. Case Rep Nephrol. 2015;2015:919763doi: 10.1155/2015/919763.
Tavares, I., Lobato, L., Matos, C., Santos, J., Moreira, P., Saraiva, M. J., & Castro Henriques, A. (2015). Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report. Case reports in nephrology, 2015919763. https://doi.org/10.1155/2015/919763
Tavares, Isabel, et al. "Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report." Case reports in nephrology vol. 2015 (2015): 919763. doi: https://doi.org/10.1155/2015/919763
Tavares I, Lobato L, Matos C, Santos J, Moreira P, Saraiva MJ, Castro Henriques A. Homozygosity for the E526V Mutation in Fibrinogen A Alpha-Chain Amyloidosis: The First Report. Case Rep Nephrol. 2015;2015:919763. doi: 10.1155/2015/919763. Epub 2015 Jun 23. PMID: 26199771; PMCID: PMC4493303.
Copy Download .nbib Format: NLM
Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction.

Brain pathology (Zurich, Switzerland)

Moreira PI.
PMID: 27327396
Brain Pathol. 2016 Sep;26(5):606. doi: 10.1111/bpa.12398.

No abstract available.

Cite
Moreira PI. Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction. Brain Pathol. 2016;26(5):606doi: 10.1111/bpa.12398.
Moreira, P. I. (2016). Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction. Brain pathology (Zurich, Switzerland), 26(5), 606. https://doi.org/10.1111/bpa.12398
Moreira, Paula I. "Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction." Brain pathology (Zurich, Switzerland) vol. 26,5 (2016): 606. doi: https://doi.org/10.1111/bpa.12398
Moreira PI. Mini-Symposium: Energy Demand and Energy Supply in Alzheimer's Disease - Introduction. Brain Pathol. 2016 Sep;26(5):606. doi: 10.1111/bpa.12398. PMID: 27327396; PMCID: PMC8029112.
Copy Download .nbib Format: NLM
Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast.

PloS one

Gillespie DO, Allen K, Guzman-Castillo M, Bandosz P, Moreira P, McGill R, Anwar E, Lloyd-Williams F, Bromley H, Diggle PJ, Capewell S, O'Flaherty M.
PMID: 26207913
PLoS One. 2015 Jul 24;10(7):e0134064. doi: 10.1371/journal.pone.0134064. eCollection 2015.

No abstract available.

Cite
Gillespie DO, Allen K, Guzman-Castillo M, et al. Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast. PLoS One. 2015;10(7):e0134064doi: 10.1371/journal.pone.0134064.
Gillespie, D. O., Allen, K., Guzman-Castillo, M., Bandosz, P., Moreira, P., McGill, R., Anwar, E., Lloyd-Williams, F., Bromley, H., Diggle, P. J., Capewell, S., & O'Flaherty, M. (2015). Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast. PloS one, 10(7), e0134064. https://doi.org/10.1371/journal.pone.0134064
Gillespie, Duncan O S, et al. "Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast." PloS one vol. 10,7 (2015): e0134064. doi: https://doi.org/10.1371/journal.pone.0134064
Gillespie DO, Allen K, Guzman-Castillo M, Bandosz P, Moreira P, McGill R, Anwar E, Lloyd-Williams F, Bromley H, Diggle PJ, Capewell S, O'Flaherty M. Correction: The Health Equity and Effectiveness of Policy Options to Reduce Dietary Salt Intake in England: Policy Forecast. PLoS One. 2015 Jul 24;10(7):e0134064. doi: 10.1371/journal.pone.0134064. eCollection 2015. PMID: 26207913; PMCID: PMC4514864.
Copy Download .nbib Format: NLM
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?.

Current neuropharmacology

Nunes AR, Alves MG, Moreira PI, Oliveira PF, Silva BM.
PMID: 25977676
Curr Neuropharmacol. 2014 Dec;12(6):475-89. doi: 10.2174/1570159X13666141204220539.

Diabetes mellitus (DM) is a metabolic disease that is rapidly increasing and has become a major public health problem. Type 2 DM (T2DM) is the most common type, accounting for up to 90-95% of the new diagnosed DM cases....

Cite
Nunes AR, Alves MG, Moreira PI, et al. Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?. Curr Neuropharmacol. 2014;12(6):475-89doi: 10.2174/1570159X13666141204220539.
Nunes, A. R., Alves, M. G., Moreira, P. I., Oliveira, P. F., & Silva, B. M. (2014). Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?. Current neuropharmacology, 12(6), 475-89. https://doi.org/10.2174/1570159X13666141204220539
Nunes, Ana R, et al. "Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?." Current neuropharmacology vol. 12,6 (2014): 475-89. doi: https://doi.org/10.2174/1570159X13666141204220539
Nunes AR, Alves MG, Moreira PI, Oliveira PF, Silva BM. Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?. Curr Neuropharmacol. 2014 Dec;12(6):475-89. doi: 10.2174/1570159X13666141204220539. PMID: 25977676; PMCID: PMC4428023.
Copy Download .nbib Format: NLM
Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility?.

Biochimica et biophysica acta

Martins AD, Moreira AC, Sá R, Monteiro MP, Sousa M, Carvalho RA, Silva BM, Oliveira PF, Alves MG.
PMID: 26071642
Biochim Biophys Acta. 2015 Sep;1852(9):1824-32. doi: 10.1016/j.bbadis.2015.06.005. Epub 2015 Jun 10.

Human feeding behavior and lifestyle are gradually being altered, favoring the development of metabolic diseases, particularly type 2 diabetes and obesity. Leptin is produced by the adipose tissue acting as a satiety signal. Its levels have been positively correlated...

Cite
Martins AD, Moreira AC, Sá R, et al. Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility?. Biochim Biophys Acta. 2015;1852(9):1824-32doi: 10.1016/j.bbadis.2015.06.005.
Martins, A. D., Moreira, A. C., Sá, R., Monteiro, M. P., Sousa, M., Carvalho, R. A., Silva, B. M., Oliveira, P. F., & Alves, M. G. (2015). Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility?. Biochimica et biophysica acta, 1852(9), 1824-32. https://doi.org/10.1016/j.bbadis.2015.06.005
Martins, Ana D, et al. "Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility?." Biochimica et biophysica acta vol. 1852,9 (2015): 1824-32. doi: https://doi.org/10.1016/j.bbadis.2015.06.005
Martins AD, Moreira AC, Sá R, Monteiro MP, Sousa M, Carvalho RA, Silva BM, Oliveira PF, Alves MG. Leptin modulates human Sertoli cells acetate production and glycolytic profile: a novel mechanism of obesity-induced male infertility?. Biochim Biophys Acta. 2015 Sep;1852(9):1824-32. doi: 10.1016/j.bbadis.2015.06.005. Epub 2015 Jun 10. PMID: 26071642.
Copy Download .nbib Format: NLM
Hydration status and associated dietary factors in children.

Nutricion hospitalaria

Neto M, Pinto M, Oliveira A, Padrão P, Moreira A, Moreira P.
PMID: 26615294
Nutr Hosp. 2015 Dec 01;32:10324. doi: 10.3305/nh.2015.32.sup2.10324.

No abstract available.

Cite
Neto M, Pinto M, Oliveira A, et al. Hydration status and associated dietary factors in children. Nutr Hosp. 2015;32:10324doi: 10.3305/nh.2015.32.sup2.10324.
Neto, M., Pinto, M., Oliveira, A., Padrão, P., Moreira, A., & Moreira, P. (2015). Hydration status and associated dietary factors in children. Nutricion hospitalaria, 3210324. https://doi.org/10.3305/nh.2015.32.sup2.10324
Neto, M, et al. "Hydration status and associated dietary factors in children." Nutricion hospitalaria vol. 32 (2015): 10324. doi: https://doi.org/10.3305/nh.2015.32.sup2.10324
Neto M, Pinto M, Oliveira A, Padrão P, Moreira A, Moreira P. Hydration status and associated dietary factors in children. Nutr Hosp. 2015 Dec 01;32:10324. doi: 10.3305/nh.2015.32.sup2.10324. PMID: 26615294.
Copy Download .nbib Format: NLM
Functional characterization of a yellow laccase from Leucoagaricus gongylophorus.

SpringerPlus

Ike PT, Moreira AC, de Almeida FG, Ferreira D, Birolli WG, Porto AL, Souza DH.
PMID: 26543788
Springerplus. 2015 Oct 30;4:654. doi: 10.1186/s40064-015-1464-y. eCollection 2015.

In this work we have identified, using mass spectrometry, two laccases produced by Leucoagaricus gongylophorus. One of them, Lac1Lg, was isolated, purified and characterized. Lac1Lg, a monomeric enzyme, was studied using ABTS and syringaldazine substrates. Lac1Lg presented kcat/Km almost...

Cite
Ike PT, Moreira AC, de Almeida FG, et al. Functional characterization of a yellow laccase from Leucoagaricus gongylophorus. Springerplus. 2015;4:654doi: 10.1186/s40064-015-1464-y.
Ike, P. T., Moreira, A. C., de Almeida, F. G., Ferreira, D., Birolli, W. G., Porto, A. L., & Souza, D. H. (2015). Functional characterization of a yellow laccase from Leucoagaricus gongylophorus. SpringerPlus, 4654. https://doi.org/10.1186/s40064-015-1464-y
Ike, Priscila Tomie Leme, et al. "Functional characterization of a yellow laccase from Leucoagaricus gongylophorus." SpringerPlus vol. 4 (2015): 654. doi: https://doi.org/10.1186/s40064-015-1464-y
Ike PT, Moreira AC, de Almeida FG, Ferreira D, Birolli WG, Porto AL, Souza DH. Functional characterization of a yellow laccase from Leucoagaricus gongylophorus. Springerplus. 2015 Oct 30;4:654. doi: 10.1186/s40064-015-1464-y. eCollection 2015. PMID: 26543788; PMCID: PMC4628026.
Copy Download .nbib Format: NLM
Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats.

Toxicology reports

Moreira AJ, Rodrigues G, Bona S, Cerski CT, Marroni CA, Mauriz JL, González-Gallego J, Marroni NP.
PMID: 28962366
Toxicol Rep. 2014 Nov 28;2:333-340. doi: 10.1016/j.toxrep.2014.11.015. eCollection 2015.

Hepatocellular carcinoma (HCC) is the third most frequent cause of cancer deaths throughout the world. This study was aimed to analyze oxidative stress and cell damage in a multistage model of liver carcinogenesis induced by diethylnitrosamine (DEN) in rats....

Cite
Moreira AJ, Rodrigues G, Bona S, et al. Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. Toxicol Rep. 2014;2:333-340doi: 10.1016/j.toxrep.2014.11.015.
Moreira, A. J., Rodrigues, G., Bona, S., Cerski, C. T., Marroni, C. A., Mauriz, J. L., González-Gallego, J., & Marroni, N. P. (2015). Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. Toxicology reports, 2333-340. https://doi.org/10.1016/j.toxrep.2014.11.015
Moreira, Andrea J, et al. "Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats." Toxicology reports vol. 2 (2015): 333-340. doi: https://doi.org/10.1016/j.toxrep.2014.11.015
Moreira AJ, Rodrigues G, Bona S, Cerski CT, Marroni CA, Mauriz JL, González-Gallego J, Marroni NP. Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. Toxicol Rep. 2014 Nov 28;2:333-340. doi: 10.1016/j.toxrep.2014.11.015. eCollection 2015. PMID: 28962366; PMCID: PMC5598147.
Copy Download .nbib Format: NLM
Bronchioloalveolar Carcinoma and Minimally Invasive Adenocarcinoma.

Surgical pathology clinics

Moreira AL.
PMID: 26839025
Surg Pathol Clin. 2010 Mar;3(1):1-26. doi: 10.1016/j.path.2010.03.006. Epub 2010 Jul 07.

The most recent WHO classification of lung cancer defines bronchioloalveolar carcinoma (BAC) as a noninvasive carcinoma or adenocarcinoma in situ. However, the use of this terminology is not uniform and does not reflect standardized criteria. As a result, the...

Cite
Moreira AL. Bronchioloalveolar Carcinoma and Minimally Invasive Adenocarcinoma. Surg Pathol Clin. 2010;3(1):1-26doi: 10.1016/j.path.2010.03.006.
Moreira, A. L. (2010). Bronchioloalveolar Carcinoma and Minimally Invasive Adenocarcinoma. Surgical pathology clinics, 3(1), 1-26. https://doi.org/10.1016/j.path.2010.03.006
Moreira, Andre L. "Bronchioloalveolar Carcinoma and Minimally Invasive Adenocarcinoma." Surgical pathology clinics vol. 3,1 (2010): 1-26. doi: https://doi.org/10.1016/j.path.2010.03.006
Moreira AL. Bronchioloalveolar Carcinoma and Minimally Invasive Adenocarcinoma. Surg Pathol Clin. 2010 Mar;3(1):1-26. doi: 10.1016/j.path.2010.03.006. Epub 2010 Jul 07. PMID: 26839025.
Copy Download .nbib Format: NLM
Mexazolam: clinical efficacy and tolerability in the treatment of anxiety.

Neurology and therapy

Fernandes H, Moreira R.
PMID: 26000220
Neurol Ther. 2014 Mar 29;3(1):1-14. doi: 10.1007/s40120-014-0016-7. eCollection 2014 Jun.

INTRODUCTION: Mexazolam is indicated for the management of anxiety with or without psychoneurotic conditions. In adult patients, the recommended daily dosage of mexazolam is 1-3 mg, administered three times daily. The objective of this article is to review the...

Cite
Fernandes H, Moreira R. Mexazolam: clinical efficacy and tolerability in the treatment of anxiety. Neurol Ther. 2014;3(1):1-14doi: 10.1007/s40120-014-0016-7.
Fernandes, H., & Moreira, R. (2014). Mexazolam: clinical efficacy and tolerability in the treatment of anxiety. Neurology and therapy, 3(1), 1-14. https://doi.org/10.1007/s40120-014-0016-7
Fernandes, Hélder, and Moreira, Ricardo. "Mexazolam: clinical efficacy and tolerability in the treatment of anxiety." Neurology and therapy vol. 3,1 (2014): 1-14. doi: https://doi.org/10.1007/s40120-014-0016-7
Fernandes H, Moreira R. Mexazolam: clinical efficacy and tolerability in the treatment of anxiety. Neurol Ther. 2014 Mar 29;3(1):1-14. doi: 10.1007/s40120-014-0016-7. eCollection 2014 Jun. PMID: 26000220; PMCID: PMC4381915.
Copy Download .nbib Format: NLM
Binding of similarly charged plates with counterions only.

Physical review letters

Moreira AG, Netz RR.
PMID: 11497925
Phys Rev Lett. 2001 Aug 13;87(7):078301. doi: 10.1103/PhysRevLett.87.078301. Epub 2001 Jul 26.

Similarly and highly charged plates in the presence of multivalent counterions attract each other and form electrostatically bound states. Using Monte-Carlo simulations, we obtain the interplate pressure in the global parameter space. The equilibrium plate separation, where the pressure...

Cite
Moreira AG, Netz RR. Binding of similarly charged plates with counterions only. Phys Rev Lett. 2001;87(7):078301doi: 10.1103/PhysRevLett.87.078301.
Moreira, A. G., & Netz, R. R. (2001). Binding of similarly charged plates with counterions only. Physical review letters, 87(7), 078301. https://doi.org/10.1103/PhysRevLett.87.078301
Moreira, A G, and Netz, R R. "Binding of similarly charged plates with counterions only." Physical review letters vol. 87,7 (2001): 078301. doi: https://doi.org/10.1103/PhysRevLett.87.078301
Moreira AG, Netz RR. Binding of similarly charged plates with counterions only. Phys Rev Lett. 2001 Aug 13;87(7):078301. doi: 10.1103/PhysRevLett.87.078301. Epub 2001 Jul 26. PMID: 11497925.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 474 entries